SBI COVID-19

Research Solutions for Coronavirus – SBI

Power your SARS-CoV-2 research with products that leverage SBI’s powerful lentivirus and pGreenFire 2.0 technologies

Whether you’re setting up new SARS-CoV-2 studies or continuing ongoing work, SBI’s growing family of COVID-19 Research Tools can help drive your essential pandemic-fighting discoveries. Combining SBI’s drive to innovate with our widely used lentivirus technologies—including high-titer lentivirus packaging systems, lentivector-based reporter vectors, and ready-to-use reporter cell lines—we have products to help you study cellular responses to SARS-CoV-2.

COVID-19 Research Tools

pPACK-SPIKE™ Delta (B.1.617.2) Variant Lentivector Packaging Mix

Safely explore increased transmissibility and other features of the spike protein from the CDC variant of concern SARS-CoV-2 Delta (B.1.617.2)

CATALOG NUMBER DESCRIPTION SIZE
CVD19-650A-1 pPACK-SPIKE Delta (B.1.617.2), SARS-CoV-2 “S” Pseudotype – Delta (B.1.617.2) Variant – Lentivector Packaging Mix 10 Reactions
CVD19-655A-1 pPACK-SPIKE Delta (B.1.617.2), SARS-CoV-2 “S” Pseudotype – Delta (B.1.617.2) Variant – Lentivector Packaging Mix 25 Reactions
CVD19-659A-KIT pPACK-SPIKE Delta Combo Kit, includes Cat# CVD19-650A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1) 1 Kit

pPACK-SPIKE™ Beta (B.1.351) Variant Lentivector Packaging Mix

Study the spike protein from the CDC variant of concern SARS-CoV-2 Beta (B.1.351) with lentivirus pseudotyped with the Beta spike protein

CATALOG NUMBER DESCRIPTION SIZE
pPACK-SPIKE Beta (B.1.351), SARS-CoV-2 “S” Pseudotype – Beta (B.1.351) Variant – Lentivector Packaging Mix
10 Reactions
pPACK-SPIKE Beta (B.1.351), SARS-CoV-2 “S” Pseudotype – Beta (B.1.351) Variant – Lentivector Packaging Mix
25 Reactions
pPACK-SPIKE Beta Combo Kit, includes Cat# CVD19-640A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
1 Kit

pPACK-SPIKE™ P1 Variant Spike Protein Lentivector Packaging Mix

Study the spike protein from SARS-CoV-2 Variant P1, a CDC variant of concern, with this packaging mix for lentivirus pseudotyped with the P1 spike protein

CATALOG NUMBER DESCRIPTION SIZE
pPACK-SPIKE P1, SARS-CoV-2 “S” Pseudotype – P1 Variant – Lentivector Packaging Mix
10 Reactions
pPACK-SPIKE P1, SARS-CoV-2 “S” Pseudotype – P1 Variant – Lentivector Packaging Mix
25 Reactions
pPACK-SPIKE P1 Combo Kit, includes Cat# CVD19-630A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
1 Kit

pPACK-SPIKE™ B.1.525 Variant Spike Protein Lentivector Packaging Mix

Study the spike protein from SARS-CoV-2 Variant B.1.525 with this packaging mix for lentivirus pseudotyped with the B.1.525 spike protein

CATALOG NUMBER DESCRIPTION SIZE
CVD19-620A-1 pPACK-SPIKE B.1.525, SARS-CoV-2 “S” Pseudotype – B.1.525 Variant – Lentivector Packaging Mix 10 Reactions
CVD19-625A-1 pPACK-SPIKE B.1.525, SARS-CoV-2 “S” Pseudotype – B.1.525 Variant – Lentivector Packaging Mix 25 Reactions
CVD19-629A-KIT pPACK-SPIKE B.1.525 Combo Kit, includes Cat# CVD19-620A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution(Cat# LV810A-1) 1 Kit

pPACK-SPIKE™ B.1.429 (CAL.20C) Variant Spike Protein Lentivector Packaging Mix

Study the spike protein from SARS-CoV-2 Variant B.1.429 (CAL.20C) with this packaging mix for lentivirus pseudotyped with the B.1.429 spike protein

CATALOG NUMBER DESCRIPTION SIZE
CVD19-610A-1 pPACK-SPIKE B.1.429, SARS-CoV-2 “S” Pseudotype – B.1.429 (CAL.20C) Variant – Lentivector Packaging Mix 10 Reactions
CVD19-615A-1 pPACK-SPIKE B.1.429, SARS-CoV-2 “S” Pseudotype – B.1.429 (CAL.20C) Variant – Lentivector Packaging Mix 25 Reactions
CVD19-619A-KIT pPACK-SPIKE B.1.429 Combo Kit, includes Cat# CVD19-610A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution(Cat# LV810A-1) 1 Kit

pPACK-SPIKE™ B.1.1.7 UK Variant Spike Protein Lentivector Packaging Mix

Study the spike protein from SARS-CoV-2 UK Variant B.1.1.7 with this packaging mix for lentivirus pseudotyped with the B.1.1.7 spike protein

CATALOG NUMBER DESCRIPTION SIZE
CVD19-590A-1 pPACK-SPIKE B.1.1.7, SARS-CoV-2 “S” Pseudotype – B.1.1.7 (UK) Variant – Lentivector Packaging Mix 10 Reactions
CVD19-595A-1 pPACK-SPIKE B.1.1.7, SARS-CoV-2 “S” Pseudotype – B.1.1.7 (UK) Variant – Lentivector Packaging Mix 25 Reactions
CVD19-599A-KIT pPACK-SPIKE B.1.1.7 Combo Kit, includes Cat# CVD19-590A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1) 1 Kit

pPACK-SPIKE B.1.351 S1 Mutations (RBD+D614G) Lentivector Packaging Mix

Expand your understanding of SARS-CoV-2 variants with a packaging mix for lentivirus pseudotyped with the S1 spike protein found in B.1.351 (K417N, E484K, N501Y, and D614G)

CATALOG NUMBER DESCRIPTION SIZE
CVD19-600A-1 pPACK-SPIKE B.1.351 S1 Mutations, SARS-CoV-2 “S” Pseudotype – B.1.351 (S. African) Variant – S1 Mutations (RBD+D614G) – Lentivector Packaging Mix 10 Reactions
CVD19-605A-1 pPACK-SPIKE B.1.351 S1 Mutations, SARS-CoV-2 “S” Pseudotype – B.1.351 (S. African) Variant – S1 Mutations (RBD+D614G) – Lentivector Packaging Mix 25 Reactions
CVD19-609A-KIT pPACK-SPIKE B.1.351 S1 Mutations Combo Kit, includes Cat# CVD19-600A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1) 1 Kit

pPACK-SPIKE B.1.351 RBD Mutations Lentivector Packaging Mix

Gain insight into the behavior of the SARS-CoV-2 spike protein that has three key receptor binding domain mutations found in B.1.351—K417N, E484K, N501Y.

CATALOG NUMBER DESCRIPTION SIZE
CVD19-580A-1 pPACK-SPIKE B.1.351 RBD Mutations, SARS-CoV-2 “S” Pseudotype – B.1.351 (S. African) Variant – RBD Mutations – Lentivector Packaging Mix  10 Reactions
CVD19-585A-1 pPACK-SPIKE B.1.351 RBD Mutations, SARS-CoV-2 “S” Pseudotype – B.1.351 (S. African) Variant – RBD Mutations – Lentivector Packaging Mix 25 Reactions
CVD19-589A-KIT pPACK-SPIKE B.1.351 RBD Mutations Combo Kit, includes Cat# CVD19-580A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it VirusConcentration solution (Cat# LV810A-1) 1 Kit

pPACK-SPIKE™ N501Y, SARS-CoV-2 “S” Pseudotype – N501Y Mutant – Lentivector Packaging Mix

Safely develop SARS-CoV-2 vaccines and antivirals using lentiviral particles pseudotyped with the N501Y Spike protein variant found in mouse-adapted virus.

CATALOG NUMBER DESCRIPTION SIZE
CVD19-560A-1 pPACK-SPIKE N501Y, SARS-CoV-2 “S” Pseudotype – N501Y Mutant – Lentivector Packaging Mix 10 Reactions
CVD19-570A-1 pPACK-SPIKE N501Y, SARS-CoV-2 “S” Pseudotype – N501Y Mutant – Lentivector Packaging Mix (XL) 25 Reactions
CVD19-575A-KIT  includes Cat# CVD19-560A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1) 1 Kit

pPACK-SPIKE™ D614G, SARS-CoV-2 “S” Pseudotype – D614G Mutant – Lentivector Packaging Mix

Study the SARS-CoV-2 D614G Spike protein mutant with this system for generating high titers of D614G Spike protein pseudotyped lentivirus particles.

CATALOG NUMBER DESCRIPTION SIZE
CVD19-530A-1 pPACK-SPIKE D614G, SARS-CoV-2 “S” Pseudotype – D614G Mutant – Lentivector Packaging Mix 10 Reactions
CVD19-540A-1 pPACK-SPIKE D614G, SARS-CoV-2 “S” Pseudotype – D614G Mutant – Lentivector Packaging Mix (XL) 25 Reactions
CVD19-550A-KIT pPACK-SPIKE D614G Combo Kit, includes: Cat# CVD19-530A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1) 1 Kit

pPACK-SPIKE™ SARS-CoV-2 “S” Pseudotype Lentivector Packaging Mix

Safely study SARS-CoV-2 infectivity with pPACK-SPIKE, a system for generating high titers of SARS-CoV-2 “Spike” pseudotyped lentiviral particles.

CATALOG NUMBER DESCRIPTION SIZE
CVD19-500A-1 pPACK-SPIKE SARS-CoV-2 “S” Pseudotype Lentivector Packaging Mix 10 Reactions
CVD19-510A-1 pPACK-SPIKE SARS-CoV-2 “S” Pseudotype Lentivector Packaging Mix (XL) 25 Reactions
CVD19-520A-KIT pPACK-SPIKE Combo Kit, includes Cat# CVD19-500A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1) 1 Kit

NRP1 Expression Lentivector

Quickly and reliably create cells expressing NRP1 to advance your studies of the protein’s role in SARS-CoV-2 infection and normal physiology

CVD19-140PA-1NRP1   Expression Lentivector, pCDH-CMV-NRP1-EF1α-Neo Plasmid   10 µg
CVD19-140VA-1NRP1   Expression Lentivector, pCDH-CMV-NRP1-EF1α-Neo Pre-packaged Virus   >2 x 10^6 IFUs

SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector

Streamline your COVID-19 studies with constructs expressing the SARS-CoV-2 nucelocapsid protein (N protein) – based on SBI’s robust lentivector technology.

CVD19-120PA-1 10 µg

CVD19-120VA-1 >2 x 10^6 IFUs

SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector

Streamline your COVID-19 studies with constructs expressing a humanized SARS-CoV-2 Spike Glycoprotein (S) – based on SBI’s robust lentivector technology.

CVD19-135PA-1 10 µg

CVD19-135VA-1 >2 x 10^6 IFUs

SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector

Streamline your COVID-19 studies with constructs expressing the SARS-CoV-2 Spike Glycoprotein (S) – based on SBI’s robust lentivector technology.

10 µg (Cat. # CVD19-130PA-1),
>2 x 10^6 IFUs (Cat. # CVD19-130VA-1)

ACE2 Expression Lentivector

Quickly and reliably create cells expressing ACE2 to advance your studies of the receptor’s role in SARS-CoV-2 infection and normal physiology.

10 µg (Cat. # CVD19-100PA-1),
>2 x 10^6 IFUs (Cat. # CVD19-100VA-1)

HEK293 ACE2 NRP1
Overexpression Stable Cell Line

Advance SARS-CoV-2 research with a ready-to-use stable
cell line that overexpresses both ACE2 and NRP1, a
facilitator of ACE2-mediated SARS-CoV-2 cell entry

CVD19-260A-1     2 x 10^6 Cells

HEK293 “N” SARS-CoV-2 Nucleocapsid
Overexpression Stable Cell Line

Safely study the SARS-CoV-2 nucleocapsid protein with our
ready-to-useHEK293 “N” SARS-CoV-2 Nucleocapsid
Overexpression Stable Cell Line.

CVD19-220A-1 2 x 10^6 Cells

HEK293 ACE2 Stable Cell Line

Get ACE2 studies, such as for SARS-CoV-2 research, up and running quickly with our ready-to-use HEK293 ACE2 Stable Cell Line.

2 x 10^6 Cells (Cat. # CVD19-200A-1)

“N” SARS-CoV-2 Nucleocapsid mRNA

Transiently express the SARS-CoV-2 nucleocapsid protein (N protein) in the cells of your choice with this ready-to-transfect mRNA.

CVD19-420A-1 “N” SARS-CoV-2 Nucleocapsid mRNA (10 µg, Transfection-ready) 10 µg
CVD19-425A-1 “N” SARS-CoV-2 Nucleocapsid mRNA (20 µg, Transfection-ready) 20 µg

“S” SARS-CoV-2 Spike Glycoprotein mRNA

Transiently express the SARS-CoV-2 spike glycoprotein (S protein) in the cells of your choice with this ready-to-transfect mRNA.

CVD19-430A-1 “S” SARS-CoV-2 Spike Glycoprotein mRNA (10 µg, Transfection-ready) 10 µg
CVD19-435A-1 “S” SARS-CoV-2 Spike Glycoprotein mRNA (20 µg, Transfection-ready) 20 µg

SUPPORT

outstanding technical support

PRODUCT

we offer a full product guarantee

DELIVERY

we offer free delivery to UK universities and non profit organisations